FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2271335192> ?p ?o ?g. }

• W2271335192 endingPage "173P" @default.
• W2271335192 startingPage "135P" @default.
• W2271335192 abstract "British Journal of PharmacologyVolume 40, Issue 1 p. 135P-173P Free Access PROCEEDINGS OF THE BRITISH PHARMACOLOGICAL SOCIETY, 8TH-9TH-10TH July, 1970 First published: September 1970 https://doi.org/10.1111/j.1476-5381.1970.tb10618.xCitations: 1AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat REFERENCES Aldridge, W. N. (1950). Some properties of specific cholinesterase with particular reference to the mechanism of inhibition by diethyl-p-nitrophenyl thiophosphate (E 605) and analogues. Biochem. J., 46, 451– 459. Bate-Smith, E. C. & Westall, R. G. (1950). Chromatographic behaviour and chemical structure. Biochim. biophys. Acta, 4, 427– 440. Dirnhuber, P. & Cullumbine, H. (1955). The effect of anticholinesterase agents on the rat's blood pressure. Br. J. Pharmac. Chemother., 10, 12– 15. Fujita, T. & Nakajima, M. (1969). The correlation between physiological activity and physico-chemical property of the substituted phenols. Residue Rev., 25, 319– 326. Gokhale, S. D., Gulati, O. D. & Joshi, N. H. (1965). Antagonism of the blocking action of bretylium and guanethidine on the pressor effect of physostigmine in the rat. Br. J. Pharmac. Chemother., 24, 624– 631. Hansch, C. & Fujita, T. (1964). A method for the correlation of biological activity and chemical structure. J. Am. chem. Soc., 86, 1616– 1626. Main, A. R. (1964). Affinity and phosphorylation constants for the inhibition of esterases by organophosphates. Science. N.Y., 144, 992– 993. Varagi, V. (1955). The action of eserine on the blood pressure of the rat. Br. J. Pharmac. Chemother., 10, 349– 353. REFERENCES Curtis, D. R., Hösli, L. & Johnston, G. A. R. (1968). A pharmacological study of the depression of spinal neurones by glycine and related amino-acids. Exp. brain Res., 6, 1– 18. Iversen, L. L. & Neal, M. J. (1968). The uptake of 3H-γ-aminobutyric acid by slices of rat cerebral cortex. J. Neurochem., 15, 1141– 1149. Iversen, L. L., Mitchell, J. F., Neal, M. J. & Srinivasan, V. (1970). The effect of stimulation of inhibitory pathways on the release of endogenous γ-aminobutyric acid from the cat cerebral cortex. Br. J. Pharmac., 38, 452P. Krnjevi, K. & Schwartz, S. (1967). The action of γ-aminobutyric acid on cortical neurones. Exp. brain Res., 3, 320– 336. Neal, M. J. & Pickles, H. G. (1969). Uptake of 14C-glycine by spinal cord. Nature. Lond., 223, 679– 680. Srinivasan, V., Neal, M. J. & Mitchell, J. F. (1969). The effect of electrical stimulation and high potassium concentrations on the efflux of 3H-γ-aminobutyric acid from brain slices. J. Neurochem., 16, 1235– 1244. REFERENCES Abdulla, Y. H. & Hamadah, K. (1970). 3′,5′ cyclic adenosine monophosphate in depression and mania. Lancet, 1, 378– 381. Brittain, R. T. & Handley, S. L. (1967). Temperature changes produced by the injection of catecholamines and 5-hydroxytryptamine into the cerebral ventricles of the conscious mouse. J. Physiol. Lond., 192, 805– 813. Hermansen, K. (1970). Evidence for adrenergic mediation of ouabain induced arrhythmias in the guinea-pig. Acta Pharmac. tox., 28, 57– 65. Spencer, P. S. J. & Turner, T. A. R. (1969). Blockade of biogenic amine synthesis: its effect on the responses to leptazol and dexamphetamine in rats. Br. J. Pharmac., 37, 94– 103. Tanz, R. D. (1967). Possible relationship between ouabain-induced augmentation and endogenous cardiac catecholamine release. In Factors Influencing Myocardial Contractibility, ed. R. D. Tanz, F. Cavaler and J. A. Y. Roberts, pp. 563– 577. New York and London: Academic Press. REFERENCES Bradley, P. B. & Elkes, J. (1957). Effects of some drugs on the electrocortical activity of the brain. Brain, 80, 77– 117. Cavanagh, J. B. & Holland, P. (1961). Cholinesterase in the chicken nervous system. Nature. Lond., 190, 735– 736. Jones, A. W. & Levi-Montalcini, R. (1958). Patterns of differentiation of the nerve centres and fibre tracts of the avian cerebral hemispheres. Arch. Ital. Biol., 96, 231– 260. Marley, E. & Stephenson, J. D. (1968a). Intracerebral micro-infusions of drugs under controlled conditions in young chickens. J. Physiol. Lond., 196, 97– 99P. Marley, E. & Stephenson, J. D. (1968b). Intracerebral micro-infusions of amines in young chickens. J. Physiol. Lond., 196, 116– 117P. Marley, E. & Stephenson, J. D. (1969). Effects of some catecholamines infused into the hypothalamus of young chickens. Br. J. Pharmac., 36, 194– 195P. Myers, R. D. (1966). Injections of solutions into cerebral tissue: relation between volume and diffusion. Physiol. Behav., 1, 171– 174. REFERENCES Armitage, A. K. & Hall, G. H. (1967a). Effects of nicotine on the systemic blood pressure when injected into the cerebral ventricles of cats. Int. J. Neuropharmac., 6, 143– 149. Armitage, A. K. & Hall, G. H. (1967b). Further evidence relating to the mode of action of nicotine on the central nervous system. Nature. Lond., 214, 977– 999. Hall, G. H. & Reit, E. (1966). Analysis of some central actions of nicotine injected into the cerebral ventricles of cats. J. Physiol. Lond., 185, 400– 447. Key, B. J. & Marley, E. (1962). The effect of sympathomimetic amines on behaviour and electrocortical activity of the chicken. Electroenceph. clin. Neurophysiol., 14, 90– 105. REFERENCE Costa, E. & Himwich, H. E. (1959). Brain serotonin metabolism in insulin hypoglycemia In. Proceedings of the Fourth International Congress of Biochemistry, pp. 283– 290. London: Pergamon Press. Gordon, A. E. & Meldrum, B. S. (1970). The effect of insulin on brain 5-HT and 5-HIAA of rat. Biochem. Pharmac., in the Press. REFERENCES Tennen, S. S. (1968). Antagonism of the analgesic effects of morphine and other drugs by p-chloro-phenylalanine, a serotonin depletor. Psychopharmacologia, 12, 278– 285. Verri, R. A., Graeff, F. G. & Corrado, A. P. (1967). Antagonism of morphine analgesia by reserpine and α-methyltyrosine and the role played by catecholamines in morphine's analgesic actions. J. Pharm. Pharmac., 19, 264– 265. REFERENCES Beretta, C., Ferrini, R. & Glässer, A. H. (1965). 1-methyl-8β-carbobenzyloxy-aminomethyl 10α-ergoline, a potent and long-lasting 5-hydroxytryptamine antagonist. Nature. Lond., 207, 421. Killam, K. F., Killam, E. K. & Naquet, R. (1967). An animal model of light sensitive epilepsy. Electroenceph. clin. Neurophysiol., 22, 497– 513. Mawson, C. & Whittington, H. (1970). Evaluation of the peripheral and central antagonistic activities against 5-hydroxytryptamine of some new agents. Br. J. Pharmac., 39, 223P. Walter, S., Balzano, E., Vuillon-Cacciuttolo, G. & Naquet, R. (1970). Modifications des potentiels évoqués visuels et de la photosensibilité provoquées par le LSD chez le Papio papio. Rev. Neurol., in the Press. REFERENCES Chen, G. & Ensor, C. R. (1953). The combined anticonvulsant activity and toxicity of Dilantin and N-methyl-5-phenylsuccinimide. J. Lab. clin. Med., 41, 78– 83. Chen, G. & Ensor, C. R. (1954). A study of the anticonvulsant properties of phenobarbital and Dilantin. Archs int. Pharmacodyn. Thér., 100, 234– 248. Cherubin, C. (1968). Heroin dependence in Britain and the U.S.A. Br. med. J., 2, 489– 490. Fulton, C. C. (1965). An analytical study of confiscated samples of narcotic drugs. International Microfilm J. Legal Med., 1, No. 1, Card 2, G-1, 1– 8. REFERENCES Ablad, B., Brogard, M. & Ek, L. (1967). Pharmacological properties of H56/28—a β-adrenergic receptor antagonist. Acta Pharmac. Tox., 5, Suppl. 2, 9– 40. Ekue, J. M. K., Lowe, D. C. & Shanks, R. G. (1970). Comparison of the effects of propranolol and MJ1999 on cardiac β-adrenoceptors in man. Br. J. Pharmac., 38, 546– 553. Forsberg, S. A. & Johnsson, G. (1967). Hemodynamic effects of propranolol and H56/28 in man —comparative study of two β-adrenergic receptor antagonists. Acta Pharmac. Tox., 5, Suppl. 2, 75– 84. Johnsson, G., Norrby, A. & Sölvell, L. (1967). Potency and time-effect relationship in man of propranolol and H56/28. Acta Pharmac. Tox., 5, Suppl. 2, 95– 105. Turner, P. & Hill, R. C. (1968). A comparison of three beta-adrenergic receptor blocking drugs in thyrotoxic tachycardia. J. clin. Pharmac., 8, 268– 271. REFERENCES Birkett, B. A. & Chamberlain, D. A. (1966). Beta-adrenergic blockade in angina pectoris: a method of treadmill assessment. Br. med. J., 2, 500– 507. Grant, R. H. E., Keelan, P., Kernohan, R. J., Leonard, J. C., Nancekieville, L. & Sinclair, K. (1966). A multi centre trial of propranolol in angina pectoris. Am. J. Cardiol., 18, 361– 366. Hamer, J. & Sowton, E. (1966). The effects of propranolol on exercise tolerance in angina pectoris Am. J. Cardiol., 18, 354– 360. Wilson, A. G., Brooke, O. G., Lloyd, H. J. & Robinson, B. F. (1969). Mechanism of action of β-adrenergic receptor blocking agents in angina pectoris. Br. med. J., 4, 399– 401. REFERENCES Davis, L. D. & Tempte, J. V. (1969). Effects of propranolol on the transmembrane potentials of ventricular muscle and Purkinje fibres of the dog. Circulation Res., 22, 661– 677. Dohadwalla, A. N., Freedberg, A. S. & Williams, Vaughan E. M. (1969). The relevance of β-receptor blockade to ouabain-induced arrhythmias. Br. J. Pharmac., 36, 257– 267. Shevde, S. & Spilker, B. A. (1970). The action of β-receptor antagonists on intracellular cardiac potentials. Br. J. Pharmac., 38, 448P. REFERENCES MacConaill, M. & Murnaghan, M. F. (1967). Effect of adrenaline on the ventricular fibrillation threshold in the isolated rabbit heart. Br. J. Pharmac. Chemother., 31, 322– 336. Murnaghan, M. F. (1969). Biphasic effect of quinidine on the ventricular fibrillation threshold. 4th Int. Congr. Pharmacol. Basle pp. 275– 276. REFERENCES Gillespie, J. S. & Kirpekar, S. M. (1965). The inactivation of infused noradrenaline by the cat spleen. J. Physiol. Lond., 176, 205– 227. Gould, L. (1969). Phentolamine. Am. Heart J., 78, 276– 278. Grayson, J. & Mendel, D. (1961). Myocardial blood flow in the rabbit. Am. J. Physiol., 200, 968– 974. McInnes, Linda & Parratt, J. R. (1969). Studies on the mode of action of hexobendine, a prospective anti-anginal drug. Br. J. Pharmac., 37, 272– 282. Perlroth, M. G. & Harrison, D. C. (1969). Cardiogenic shock: a review. Clin. Pharmac., 10, 449– 467. Taylor, S. H., Sutherland, G. R., MacKenzie, G. J., Staunton, H. P. & Donald, K. W. (1965). The circulatory effects of intravenous phentolamine in man. Circulation, 31, 741– 754. REFERENCES Jewitt, D. E., Maurer, B. J. & Hubner, P. J. B. (1970). Increased pulmonary arterial pressures after pentazocine in myocardial infarction. Br. med. J., 1, 795. Lal, S., Savidge, R. S. & Chhabra, G. P. (1969). Cardiovascular and respiratory effects of morphine and pentazocine in patients with myocardial infarction. Lancet, 1, 379. REFERENCES Alps, B. J., Hill, Madeline, Johnson, E. S. & Wilson, A. B. (1970). Autonomic blocking properties of Wy 21901. Br. J. Pharmac., 40, 153P. Archibald, J. L. (1968). A new class of indole antihypertensive agents. Chim. Therap., 3, 397. Prichard, B. N. C. & Gillam, P. M. S. (1969). Treatment of hypertension with propranolol. Br. med. J., 1, 7– 16. Zacharias, F. J. & Cowen, K. J. (1970). Controlled trial of propranolol in hypertension. Br. med. J., 1, 471– 474. REFERENCES Alps, B. J., Johnson, E. S. & Wilson, A. B. (1970). Cardiovascular actions of Wy 21901, a new hypotensive and anti-arrhythmic agent. Br. J. Pharmac., 40, 151P. Archibald, J. L. (1968). A new class of indole antihypertensive agents. Chim. Therap., 3, 397. Arunlakshana, O. & Schild, H. O. (1959). Some quantitative uses of drug antagonists. Br. J. Pharmac. Chemother., 14, 48– 58. Bülbring, E. & Wajda, I. (1945). Biological comparison of local anaesthetics. J. Pharmac. exp. Ther., 86, 78– 84. Davis, W. G. (1970). A comparison of the local anaesthetic—“quinidine-like”—and adrenergic β-blocking-activities of five β-receptor antagonists. J. Pharm. Pharmac., 22, 284– 290. REFERENCE Lowry, O. H., Passonneau, J. V., Hasselberger, F. X. & Schulz, D. W. (1964). Effect of ischemia on known substrates and cofactors of the glycolytic pathway in brain. J. biol. Chem., 239, 18– 30. REFERENCES Ahlquist, R. P. & Levy, B. (1959). Adrenergic receptive mechanism of canine ileum. J. Pharmac. exp. Ther., 127, 146– 149. Bartlet, A. L. & Hassan, T. (1969). Types of adrenergic receptor in chick rectum and guinea-pig colon. In Abstracts of the Fourth International Congress on Pharmacology, July 14–18, Basel, Switzerland, p. 128. Black, J. W., Duncan, W. A. M. & Shanks, R. G. (1965). Comparison of some properties of pronethalol and propranolol. Br. J. Pharmac. Chemother., 25, 577– 591. Blinks, J. R. (1967). Evaluation of the cardiac effects of several β-adrenergic blocking agents. An. N.Y. Acad. Sci., 139, 673– 685. Farmer, J. B. & Levy, G. P. (1969). β-Adrenoreceptive receptors in the guinea-pig. In Abstracts of the Fourth International Congress on Pharmacology, July 14–18, Basel, Switzerland, pp. 358– 359. Patil, P. N. (1967). Steric aspects of adrenergic drugs. VIII. Optical isomers of β-adrenergic receptor antagonists. J. Pharmac. exp. Ther., 160, 308– 314. REFERENCES Birmingham, A. T. & Szolcsànyi, J. (1965). Competitive blockade of adrenergic α-receptors and histamine receptors by thymoxamine. J. Pharm. Pharmac., 17, 449– 458. Birmingham, A. T., Ernest, K. & Newcombe, J. F. (1969). Antagonism of the response of human isolated arteries to noradrenaline. Br. J. Pharmac., 35, 127– 131. Coupar, I. M. & Turner, P. (1969). Relative potencies of sympathetic amines on isolated human smooth muscle. Br. J. Pharmac., 36, 213P. Lockett, M. F. & Bartlet, A. L. (1956). A method for the determination of pA2 in 2 minutes. J. Pharm. Pharmac., 8, 18– 26. Schild, H. O. (1947). pA, a new scale for the measurement of drug antagonism. Br. J. Pharmac. Chemother., 2, 189– 206. Schild, H. O. (1957). Drug antagonism and pAx. Pharmac. Rev., 9, 242– 246. Zaimis, E. & Hanington, E. (1969). A possible pharmacological approach to migraine. Lancet, 2, 298– 300. REFERENCES Graham, J. D. P. & Katib, H. A. (1966). The action of trypsin on blockade by 2-haloalkylamines: speculation on the nature of the alpha receptor for catecholamines. Br. J. Pharmac. Chemother., 28, 1– 14. Mottram, D. R. & Graham, J. D. P. (1970). The reversal by trypsin of the action of a 2-haloalkylamine. J. Pharm. Pharmac., 22, 316– 317. Takagi, K. & Takahashi, A. (1968). Studies of separation and characterisation of acetylcholine receptor labelled with tritiated dibenamine. Biochem. Pharmac., 17, 1609– 1618. REFERENCES Löffelholz, K. & Muscholl, E. (1969). A muscarinic inhibition of the noradrenaline release evoked by postganglionic sympathetic nerve stimulation. Arch. exp. Path. Pharmak., 265, 1– 15. Malik, K. U. & Ling, G. M. (1969a). Modification by acetylcholine of the response of rat mesenteric arteries to sympathetic stimulation. Circulation Res., 25, 1– 9. Malik, K. U. & Ling, G. M. (1969b). The effect of 1,1-dimethyl-4-phenyl-piperazinium on the response of mesenteric arteries to sympathetic nerve stimulation. J. Pharm. Pharmac., 21, 514– 519. Rand, M. J. & Varma, B. (1970). The effects of cholinomimetic drugs on responses to sympathetic nerve stimulation and noradrenaline in the rabbit ear artery. Br. J. Pharmac., 38, 758– 770. Roszkowski, A. P. (1961). An unusual type of sympathetic ganglionic stimulant. J. Pharmac. exp. Ther., 132, 157– 170. REFERENCES Boura, A. L. A. & Green, A. F. (1965). Adrenergic neurone blocking agents. Ann. Rev. Pharmac., 5, 183– 212. Rand, M. J. & Wilson, J. (1967). The relationship between adrenergic neurone blocking activity and local anaesthetic activity in a series of guanidine derivatives. Eur. J. Pharmac., 1, 200– 209. REFERENCES Bell, G. H. & Robson, J. M. (1937). The effect of certain hormones on the activity of the uterine muscle of the guinea-pig. J. Physiol. Lond., 88, 312– 327. Diamond, J. & Brody, T. M. (1966). Hormonal alteration of the response of the rat uterus to catecholamines. Life Sci. Oxford, 5, 2187– 2193. Levy, B. & Tozzi, S. (1963). The adrenergic receptive mechanism of the rat uterus. J. Pharmac. exp. Ther., 142, 178– 184. Mann, Monica (1949). Sympathin and the rat uterus. J. Physiol. Lond., 110, 11P. Rudzik, A. D. & Miller, J. W. (1962). The mechanism of uterine inhibitory action of relaxin-containing extracts. J. Pharmac. exp. Ther., 138, 82– 87. Tothill, Anne (1967). Investigation of adrenaline reversal in the rat uterus by the induction of resistance to isoprenaline. Br. J. Pharmac. Chemother., 29, 291– 301. REFERENCES Beckett, A. H., Belthle, F. W., Fell, K. R. & Lockett, M. F. (1954). The active constituents of raspberry leaves. J. Pharm. Pharmac., 6, 785– 794. Burn, J. H. & Withell, E. R. (1941). A principle in raspberry leaves which relaxes uterine muscle. Lancet, 2, 1– 3. Gerard, J. (1597). The herbal, or a General History of Plants. London: E. Bollifant, for B. and J. Norton. Tothill, A. (1967). Investigation of adrenaline reversal in the rat uterus by the induction of resistance to isoprenaline. Br. J. Pharmac. Chemother., 29, 291– 301. Whitehouse, B. (1941). Fragarine: an inhibitor of uterine action. Br. med. J., 2, 370– 371. REFERENCES Cowie, A. L., Kosterlitz, H. W. & Watt, A. J. (1968). Mode of action of morphine-like drugs on autonomic neuro-effectors. Nature. Lond., 220, 1040– 1042. Paton, W. D. M. & Zar, M. A. (1968). The origin of acetylcholine released from guinea-pig intestine and longitudinal muscle fibres. J. Physiol. Lond., 194, 13– 33. REFERENCES Ambache, N. (1957). Properties of irin, a physiological constituent of the rabbit's iris. J. Physiol. Lond., 135, 114– 132. Ambache, N. (1959). Further studies on the preparation, purification and nature of irin. J. Physiol. Lond., 146, 255– 294. Ambache, N., Kavanagh, L. & Whiting, J. (1965). Effect of mechanical stimulation on rabbit's eyes: release of active substance in anterior chamber perfusates. J. Physiol. Lond., 176, 378– 403. Ambache, N., Brummer, H. C., Rose, J. G. & Whiting, J. (1966). Thin-layer chromatography of spasmogenic unsaturated hydroxy-acids from various tissues. J. Physiol. Lond., 185, 77– 78P. ÅNggård, E. & Samuelsson, B. (1964). Smooth muscle stimulating lipids in sheep iris. The identification of prostaglandin F2α. Biochem. Pharmac., 13, 281– 283. Fleshler, B. & Bennett, A. (1969). Responses of human, guinea-pig and rat colonic circular muscle to prostaglandins. J. lab. clin. Med., 74, 872– 873. Gréen, K. & Samuelsson, B. (1964). Prostaglandins and related factors. XIX. Thin layer chromatography of prostaglandins. J. lipid Res., 5, 117– 120. Sanner, J. H. (1969). Antagonism of Prostaglandin E2 by 1-acetyl-2-(8-chloro-10,11-dihydrodibenz (b f) (1,4) oxazepine-10-carbonyl) hydrazine (SC-19220). Archs int. Pharmacodyn. Thér., 180, 46– 56. Waitzman, M. B., Bailey, W. R. & Kirby, C. G. (1967). Chromatographic analysis of biologically active lipids from rabbit irides. Exp. Eye Res., 6, 130– 137. REFERENCES Medina, M. A., Londez, J. H. & Foster, L. L. (1969). Inhibition of tissue histamine formation by decaborane. J. Pharmac. exp. Ther., 169, 132– 137. Merritt, J. H. & Sulkowski, T. S. (1967). Inhibition of aromatic-l-amino acid decarboxylation by decaborane. Biochem. Pharmac., 16, 369– 373. REFERENCES Buckett, W. R., Marjoribanks, C. E. B., Marwick, F. A. & Morton, M. B. (1968). The pharmacology of pancuronium bromide (Org. NA97), a new potent steroidal neuromuscular blocking agent. Br. J. Pharmac. Chemother., 32, 671– 682. Buckett, W. R. & Saxena, P. R. (1969). The pharmacology of dacuronium bromide—a new short acting neuromuscular blocking drug of non-depolarising typeAbstr. 4th. International Congress on Pharmacology, Basel, p. 420. Frisk-Holmberg, M. & Uvnäs, B. (1969). The mechanism of histamine release from isolated rat peritoneal mast cells induced by d-tubocurarine. Acta physiol. scand., 76, 335– 339. Konzett, H. & Rössler, R. (1940). Versuchsanordnung Zu Untersuchungen an der Bronchial-muskulatur. Naunyn-Schmiedebergs Arch exp. Path. Pharmak., 195, 71– 74. REFERENCES Aitken, M. M. & Sanford, J. (1969). Experimental anaphylaxis in cattle. J. comp. Path., 79, 131– 139. Aitken, M. M. & Sanford, J. (1970). The effect of drugs on bovine tracheobronchial and pulmonary vascular tissue. Br. J. Pharmac., 38, 443P. Alexander, F., Eyre, P., Head, K. W. & Sanford, J. (1970). Effects of anaphylaxis and chemical histamines in sheep. J. comp. Path., 80, 19– 30. Bywater, R. J. (1969). Some responses of bovine intestinal musculature to humoral agents in vitro and in vivo. Archs int. Pharmacodyn. Thér., 179, 459– 468. REFERENCES Graeme, M. L., Fabry, E. & Sigg, E. B. (1966). Mycobacterial adjuvant periarthritis in rodents and its modification by anti-inflammatory agents. J. Pharmac. exp. Ther., 153, 373– 380. Newbould, B. B. (1963). Chemotherapy of arthritis induced in rats by mycobacterial adjuvant. Br. J. Pharmac. Chemother., 21, 127– 136. Pearson, C. M. (1956). Development of arthritis, periarthritis and periostitis in rats given adjuvants. Proc. Soc. exp. Biol. Med., 91, 95– 101. Piliero, S. J. & Colombo, C. (1967). A new in vivo assay for screening drugs for potential anti-4inflammatory activity. Clin. Pharmac. J. new Drugs, 7, 198– 206. Ward, J. R., Cloud, R. S., Krawitt, E. L. & Jones, R. S. (1964). Studies on adjuvant induced polyarthritis in rats. III The effect of “immunosuppressive agents” on arthritis and tuberculin hypersensitivity. Arthritis Rheum., 7, 654– 661. REFERENCES Code, C. F. (1960). The semantics of the process of absorption. Perspect. biol. Med., 3, 560– 562. Smith, H. W. & Halls, S. (1967). Studies on Escherichia coli enterotoxin. J. path. Bact., 93, 531– 543. REFERENCES Butler, A. M. & Cushman, M. (1940). Distribution of ascorbic acid in the blood. J. clin. Invest., 19, 459– 467. Butler, A. M., Cushman, M. & MacLachlan, E. A. (1943). The determination of ascorbic acid in whole blood and its constituents by means of methylene-blue—macro and micro methods. J. biol. Chem., 150, 453– 461. Crandon, J. H., Lund, C. C. & Dill, D. B. (1940). Experimental human scurvy. New Engl. J. Med., 223, 353– 369. Denson, K. W. & Bowers, E. F. (1961). The determination of ascorbic acid in white blood cells. A comparison of W.B.C. ascorbic acid and phenolic acid excretion in elderly patients. Clin. Sci., 21, 157– 162. Hughes, R. E. & Maton, S. C. (1968). The passage of vitamin C across the erythrocyte membrane. Br. J. Haemat., 14, 247– 253. Milne, M. D. (1964). Disorders of amino-acid transport. Br. med. J., 1, 327– 336. REFERENCES Evans, J. R. & Hughes, R. E. (1963). The growth maintaining activity of ascorbic acid. Br. J. Nutr., 17, 253– 255. Hodges, R. J. & Hotston, R. T. (1970). Pituitary-adrenocortical activity in the ascorbic acid deficient guinea-pig. Br. J. Pharmac., 39, 193P. REFERENCES Bond, E. J., Butler, W. H., DeMatteis, F. & Barnes, J. M. (1969). Effects of carbon disulphide on the livers of rats. Br. J. industr. Med., 26, 335– 337. Bond, E. J. & DeMatteis, F. (1969). Biochemical changes in rat liver administration of carbon disulphide, with particular reference to microsomal changes. Biochem. Pharmac., 18, 2531– 2549. Djuric, D., Surducki, N. & Berkes, I. (1965). Iodine-azide test on urine of persons exposed to carbon disulphide. Br. J. industr. Med., 22, 321– 323. Strickland, R. D., Mack, P. A. & Childs, W. A. (1960). Determination of cystine by its catalytic effect on the iodine-azide reaction. Anal. Chem., 32, 430– 436. Citing Literature Volume40, Issue1September 1970Pages 135P-173P ReferencesRelatedInformation" @default.
• W2271335192 created "2016-06-24" @default.
• W2271335192 date "1970-09-01" @default.
• W2271335192 modified "2023-10-17" @default.
• W2271335192 title "PROCEEDINGS OF THE BRITISH PHARMACOLOGICAL SOCIETY, 8TH-9TH-10TH July, 1970" @default.
• W2271335192 cites W151877005 @default.
• W2271335192 cites W1964610854 @default.
• W2271335192 cites W1966866092 @default.
• W2271335192 cites W1967969417 @default.
• W2271335192 cites W1968291223 @default.
• W2271335192 cites W1970342669 @default.
• W2271335192 cites W1971398075 @default.
• W2271335192 cites W1972024533 @default.
• W2271335192 cites W1973576388 @default.
• W2271335192 cites W1973582371 @default.
• W2271335192 cites W1974919652 @default.
• W2271335192 cites W1978099366 @default.
• W2271335192 cites W1978134854 @default.
• W2271335192 cites W1980519868 @default.
• W2271335192 cites W1981869978 @default.
• W2271335192 cites W1988104183 @default.
• W2271335192 cites W1988227732 @default.
• W2271335192 cites W1989873666 @default.
• W2271335192 cites W1990141031 @default.
• W2271335192 cites W1990546626 @default.
• W2271335192 cites W1991097268 @default.
• W2271335192 cites W1991446640 @default.
• W2271335192 cites W1995803479 @default.
• W2271335192 cites W1997106177 @default.
• W2271335192 cites W2002402889 @default.
• W2271335192 cites W2002865586 @default.
• W2271335192 cites W2005391013 @default.
• W2271335192 cites W2007741054 @default.
• W2271335192 cites W2010587126 @default.
• W2271335192 cites W2012887246 @default.
• W2271335192 cites W2021015648 @default.
• W2271335192 cites W2021264760 @default.
• W2271335192 cites W2022090382 @default.
• W2271335192 cites W2022865459 @default.
• W2271335192 cites W2022975304 @default.
• W2271335192 cites W2023464578 @default.
• W2271335192 cites W2024136403 @default.
• W2271335192 cites W2025798061 @default.
• W2271335192 cites W2028246719 @default.
• W2271335192 cites W2028689079 @default.
• W2271335192 cites W2028946850 @default.
• W2271335192 cites W2029670216 @default.
• W2271335192 cites W2029827323 @default.
• W2271335192 cites W2030884112 @default.
• W2271335192 cites W2031974929 @default.
• W2271335192 cites W2033938927 @default.
• W2271335192 cites W2035980652 @default.
• W2271335192 cites W2040198821 @default.
• W2271335192 cites W2040607968 @default.
• W2271335192 cites W2041221928 @default.
• W2271335192 cites W2042740007 @default.
• W2271335192 cites W2043192411 @default.
• W2271335192 cites W2043652770 @default.
• W2271335192 cites W2044737826 @default.
• W2271335192 cites W2045767959 @default.
• W2271335192 cites W2050324269 @default.
• W2271335192 cites W2050412981 @default.
• W2271335192 cites W2050809036 @default.
• W2271335192 cites W2050939471 @default.
• W2271335192 cites W2052097565 @default.
• W2271335192 cites W2052226480 @default.
• W2271335192 cites W2057971042 @default.
• W2271335192 cites W2059423328 @default.
• W2271335192 cites W2064085750 @default.
• W2271335192 cites W2065942105 @default.
• W2271335192 cites W2066144252 @default.
• W2271335192 cites W2067390126 @default.
• W2271335192 cites W2071616818 @default.
• W2271335192 cites W2074157829 @default.
• W2271335192 cites W2074688360 @default.
• W2271335192 cites W2074768280 @default.
• W2271335192 cites W2078237064 @default.
• W2271335192 cites W2078309987 @default.
• W2271335192 cites W2080921495 @default.
• W2271335192 cites W2081624231 @default.
• W2271335192 cites W2083522762 @default.
• W2271335192 cites W2086670553 @default.
• W2271335192 cites W2087636127 @default.
• W2271335192 cites W2092159743 @default.
• W2271335192 cites W2092358926 @default.
• W2271335192 cites W2095378700 @default.
• W2271335192 cites W2112707636 @default.
• W2271335192 cites W2115463644 @default.
• W2271335192 cites W2121063203 @default.
• W2271335192 cites W2122469725 @default.
• W2271335192 cites W2131198075 @default.
• W2271335192 cites W2134157989 @default.
• W2271335192 cites W2167542296 @default.
• W2271335192 cites W2171285254 @default.
• W2271335192 cites W2172157515 @default.
• W2271335192 cites W2222674581 @default.
• W2271335192 cites W2331507609 @default.
• W2271335192 cites W2419007943 @default.

• next